keyword
https://read.qxmd.com/read/38532261/erratum-pharmacokinetics-of-a-single-transdermal-dose-of-mirtazapine-in-rhesus-macaques-macaca-mulatta
#21
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 1, 2024: Comparative Medicine
https://read.qxmd.com/read/38500267/the-effective-perospirone-augmentation-with-clonazepam-for-treatment-resistant-burning-mouth-syndrome-a-case-report
#22
Motoko Watanabe, Chihiro Takao, Chizuko Maeda, Gayatri Nayanar, Risa Tominaga, Yasuyuki Kimura, Trang Thi Huyen Tu, Takahiko Nagamine, Akira Toyofuku
Burning mouth syndrome (BMS) is characterized by burning sensations in the oral region without corresponding abnormalities and is often accompanied by uncomfortable sensations. Herein, we present cases of BMS in which the remaining uncomfortable sensations improved with perospirone augmentation with clonazepam. Case 1: A 61-year-old man complained of a burning pain in his tongue, a sensation of dryness and discomfort as if his tongue was sticking to a palatal plate. With the diagnosis of BMS, psychopharmacotherapy was initiated with amitriptyline...
March 18, 2024: Neuropsychopharmacology Reports
https://read.qxmd.com/read/38451521/drug-efficacy-in-the-treatment-of-antipsychotic-induced-akathisia-a-systematic-review-and-network-meta-analysis
#23
JOURNAL ARTICLE
Cyril Gerolymos, Romain Barazer, Dong Keon Yon, Anderson Loundou, Laurent Boyer, Guillaume Fond
IMPORTANCE: Antipsychotic-induced akathisia (AIA) occurs in 14% to 35% of patients treated with antipsychotics and is associated with increased suicide and decreased adherence in patients with schizophrenia. However, no comprehensive review and network meta-analysis has been conducted to compare the efficacy of treatments for AIA. OBJECTIVE: To compare the efficacy associated with AIA treatments. DATA SOURCES: Three databases (MEDLINE, Web of Science, and Google Scholar) were systematically searched by multiple researchers for double-blind randomized clinical trials (RCTs) comparing active drugs for the treatment of AIA with placebo or another treatment between May 30 and June 18, 2023...
March 4, 2024: JAMA Network Open
https://read.qxmd.com/read/38436664/-treatment-resistance-in-anxiety-disorders-definition-and-treatment-options
#24
REVIEW
Katharina Domschke, Andreas Ströhle, Peter Zwanzger
Treatment resistance in anxiety disorders represents a clinical challenge, contributes to the chronicity of the diseases as well as sequential comorbidities, and is associated with a significant individual and socioeconomic burden. This narrative review presents the operational definition of treatment resistance in anxiety disorders according to international consensus criteria (< 50% reduction in the Hamilton Anxiety Scale, HAM‑A, score or < 50% reduction in the Beck Anxiety Inventory, BAI, score or a clinical global impression-improvement, CGI‑I, score > 2)...
March 4, 2024: Der Nervenarzt
https://read.qxmd.com/read/38435137/rhabdomyolysis-associated-with-mirtazapine-and-quetiapine-therapy-a-case-report-and-review-of-the-literature
#25
Gerard Heng, Teck Hwee Soh, Cecilia Kwok
Rhabdomyolysis has been reported as a rare adverse effect of psychotropic use. This paper presents a case of rhabdomyolysis in a 39-year-old man with depression and substance use disorder. He had been started on quetiapine two months before and mirtazapine two weeks before developing symptoms of pain and weakness. His creatine kinase (CK) was elevated to 5870 U/L, with no other contributing factors elicited. He improved with symptomatic treatment along with cessation of psychotropics. A literature review on rhabdomyolysis associated with quetiapine and/or mirtazapine therapy found 12 cases with quetiapine, one case with mirtazapine, and three cases with quetiapine and mirtazapine combination treatment...
February 2024: Curēus
https://read.qxmd.com/read/38432647/national-trends-in-antidepressant-use-in-australian-residential-aged-care-facilities-2006-2019
#26
JOURNAL ARTICLE
Georgina A Hughes, Maria C Inacio, Debra Rowett, Catherine Lang, Robert N Jorissen, Megan Corlis, Janet K Sluggett
OBJECTIVES: Antipsychotics have been the focus of reforms for improving the appropriateness of psychotropic medicine use in residential aged care facilities (RACFs). Comprehensive evaluation of antidepressant use in RACFs is required to inform policy and practice initiatives targeting psychotropic medicines. This study examined national trends in antidepressant use among older people living in RACFs from 2006 to 2019. DESIGN: National repeated cross-sectional study...
February 29, 2024: Journal of the American Medical Directors Association
https://read.qxmd.com/read/38401406/residual-effects-of-medications-for-sleep-disorders-on-driving-performance-a-systematic-review-and-network-meta-analysis-of-randomized-controlled-trials-nma-driving-and-hypnotics
#27
JOURNAL ARTICLE
Michele Fornaro, Claudio Caiazza, Flavia Rossano, Flavia Cilmi, Michele De Prisco, Eduard Vieta, Trevor Thompson, Marco Solmi, Andre Ferrer Carvalho, Felice Iasevoli, Andrea de Bartolomeis
Sleep medications often carry residual effects potentially affecting driving safety, warranting network meta-analysis (NMA). PubMed/EMBASE/TRID/Clinicaltrials.gov/WHO-ICTRP/WebOfScience were inquired for randomized controlled trials of hypnotic driving studies in persons with insomnia and healthy subjects up to 05/28/2023, considering the vehicle's standard deviation of lateral position - SDLP (Standardized Mean Difference/SMD) and driving impairment rates on the first morning (co-primary outcomes) and endpoint...
February 23, 2024: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://read.qxmd.com/read/38395251/oral-mirtazapine-decreases-the-gastrointestinal-adverse-effects-in-cats-on-doxorubicin-chemotherapy
#28
JOURNAL ARTICLE
C H Lee, S L Wang
Anorexia, depression, and vomiting are the common adverse effects of chemotherapy in humans and animals. Mirtazapine is primarily used as an appetite stimulant and antiemetic in dogs and cats. Therefore, we evaluated the efficacy of mirtazapine in reducing the gastrointestinal adverse effects in cats receiving doxorubicin chemotherapy. This single-masked, placebo-controlled crossover study enrolled 11 cats with malignant mammary gland tumors. The cats were randomly assigned to receive either mirtazapine (1...
February 21, 2024: Veterinary Journal
https://read.qxmd.com/read/38392605/developing-a-model-for-quantifying-qtc-prolongation-risk-to-enhance-medication-safety-assessment-a-retrospective-analysis
#29
JOURNAL ARTICLE
Luis Giovannoni, Gerd A Kullak-Ublick, Alexander Jetter
There are currently no established methods to predict quantitatively whether the start of a drug with the potential to prolong the QTc interval poses patients at risk for relevant QTc prolongation. Therefore, this retrospective study aimed to pave the way for the development of models for estimating QTc prolongation in patients newly exposed to medications with QTc-prolonging potential. Data of patients with a documented QTc prolongation after initiation of a QTc-prolonging drug were extracted from hospital charts...
January 31, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38380193/dolichocephaly-arachnodactyly-diplopia-and-distal-myopathy-novel-phenotype-of-micu1-variant-c-553c-t
#30
Josef Finsterer, Awini Barwari
Pathogenic variants in mitochondrial calcium uptake 1 ( MICU1)  manifest phenotypically heterogeneously but most frequently in the brain and skeletal muscle. Dolichocephaly, arachnodactyly, diplopia, and distal myopathy have not been reported in carriers of a pathogenic  MICU1  variant. The patient is a 23-year-old female with consanguineous parents (first cousins) who was a carrier of the homozygous  MICU1  variant c.553C>T, phenotypically presenting with developmental delay, intellectual disability, ataxia, dysmorphia (dolichocephaly, arachnodactyly, clinodactyly, hypertelorism, wide nasal bridge), myopathy (ptosis, double vision, strabismus, distal limb weakness, diffuse wasting, hypotonia), hyperextensible joints and hyperkyphosis...
January 2024: Curēus
https://read.qxmd.com/read/38379028/comparative-responses-to-17-different-antidepressants-in-major-depressive-disorder-results-from-a-2-year-long-term-nation-wide-population-based-study-emulating-a-randomized-trial
#31
JOURNAL ARTICLE
Lars Vedel Kessing, Simon Christoffer Ziersen, Frederik Mølkjaer Andersen, Thomas Gerds, Esben Budtz-Jørgensen
BACKGROUND: Long-term studies comparing nonresponse to antidepressants for major depressive disorder (MDD) are lacking. AIMS: To present systematic population-based nation-wide register data on comparative 2-year non-response within six antidepressant drug classes and 17 different antidepressants in patients with MDD. METHOD: The study included all 106,920 patients in Denmark with a first main index diagnosis of MDD at a psychiatric hospital inpatient or outpatient contact and who subsequently had a purchase of an antidepressant in the period from 1995 to 2018...
February 20, 2024: Acta Psychiatrica Scandinavica
https://read.qxmd.com/read/38376620/nose-to-brain-delivery-of-mirtazapine-via-lipid-nanocapsules-preparation-statistical-optimization-radiolabeling-in-vivo-biodistribution-and-pharmacokinetic-study
#32
JOURNAL ARTICLE
Mennatullah M Ibrahim, Emad B Basalious, Mohamed A El-Nabarawi, Amal Ia Makhlouf, Marwa Eid Sayyed, Ismail Taha Ibrahim
Mirtazapine (MZPc) is an antidepressant drug which is approved by the FDA. It has low bioavailability, which is only 50%, in spite of its rapid absorption when orally administered owing to high first-pass metabolism. This study was oriented towards delivering intranasal (IN) mirtazapine by a direct route to the brain by means of preparing lipid nanocapsules (LNCs) as a targeted drug delivery system. MZP-LNCs were constructed by solvent-free phase inversion temperature technique applying D-Optimal mixture design to study the impact of 3 formulation variables on the characterization of the formulated nanocapsules...
February 20, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38376419/statement-of-retraction-mirtazapine-prevents-cell-activation-inflammation-and-oxidative-stress-against-isoflurane-exposure-in-microglia
#33
(no author information available yet)
No abstract text is available yet for this article.
December 2024: Bioengineered
https://read.qxmd.com/read/38354747/the-relevance-of-integrating-cyp2c19-phenoconversion-effects-into-clinical-pharmacogenetics
#34
JOURNAL ARTICLE
Maike Scherf-Clavel, Heike Weber, Stefan Unterecker, Amelie Frantz, Andreas Eckert, Andreas Reif, Jürgen Deckert, Martina Hahn
INTRODUCTION: CYP2D6 and CYP2C19 functional status as defined by genotype is modulated by phenoconversion (PC) due to pharmacokinetic interactions. As of today, there is no data on the effect size of PC for CYP2C19 functional status. The primary aim of this study was to investigate the impact of PC on CYP2C19 functional status. METHODS: Two patient cohorts (total n=316; 44.2±15.4 years) were investigated for the functional enzyme status of CYP2C19 applying two different correction methods (PCBousman , PCHahn&Roll ) as well as serum concentration and metabolite-to-parent ratio of venlafaxine, amitriptyline, mirtazapine, sertraline, escitalopram, risperidone, and quetiapine...
February 14, 2024: Pharmacopsychiatry
https://read.qxmd.com/read/38353837/mirtazapine-loaded-polymeric-micelles-for-rapid-release-tablet-a-novel-formulation-in-vitro-and-in-vivo-studies
#35
JOURNAL ARTICLE
Sara Nageeb El-Helaly, Amira A Rashad
Major depression is a prevalent disorder characterized by sadness, lack of interest or pleasure, interrupted sleep or food, and impaired concentration. Mirtazapine (MTZ), a tetracyclic antidepressant drug, is commonly used to treat moderate to severe depression. MTZ is classified as a BCS class II drug that has shown bioavailability of 50% due to extensive first-pass metabolism. The aim of this research is to develop a delivery platform with enhanced solubility and oral bioavailability of MTZ through formulating polymeric micelles modeled in a rapid release tablet...
February 14, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38353811/edema-related-to-treatment-with-psychotropic-drugs
#36
JOURNAL ARTICLE
Johanna Engel, Beatrice Haack, Oliver Zolk, Timo Greiner, Martin Heinze, Sermin Toto, Johanna Seifert, Stefan Bleich, Catherine Glocker, Renate Grohmann, Michael Schneider, Susanne Stübner
Edema as an adverse drug reaction is a commonly underestimated yet potentially debilitating condition. This study analyzes the incidence of severe psychotropic drug-induced edema (e.g., edema affecting the face, legs, or multiple body parts and lasting for more than 1 week, or in any case necessitating subsequent diuretic use) among psychiatric inpatients. The cases under examination are derived from an observational pharmacovigilance program conducted in German-speaking countries ("Arzneimittelsicherheit in der Psychiatrie", AMSP) from 1993 to 2016...
February 14, 2024: Journal of Neural Transmission
https://read.qxmd.com/read/38338419/direct-immersion-solid-phase-microextraction-for-therapeutic-drug-monitoring-of-patients-with-mood-disorders
#37
JOURNAL ARTICLE
Magdalena Świądro-Piętoń, Dominika Dudek, Renata Wietecha-Posłuszny
This article discusses a new method for monitoring drug concentrations in blood samples from patients with mood disorders. The method uses solid-phase microextraction to extract analytes directly from blood samples. It has been adapted to identify the most commonly used drugs in mood disorders, including amitriptyline, citalopram, fluoxetine, paroxetine, sertraline, trazodone, duloxetine, venlafaxine, lamotrigine, quetiapine, olanzapine, and mirtazapine. The analysis is carried out using high-performance liquid chromatography coupled with mass spectroscopy...
January 31, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38334395/formulation-optimization-and-full-characterization-of-mirtazapine-loaded-aquasomes-a-new-technique-to-boost-antidepressant-effects
#38
JOURNAL ARTICLE
Lamiaa Mohamed Hussein Ali, Aya Mohamed Dawaba, Shereen Ahmed El-Adawy
ObjectiveThe development of Mirtazapine (MRT)-loaded aquasomes by co-precipitation sonication technique to boost the antidepressant potential of MRT.MethodologyMRT-loaded aquasomes formulations were prepared using Box-Behnken design to investigate the effect of independent factors including sonication time (X1), sonication temperature (X2), and sugar concentration (X3) on the dependent variables as particle size and drug loading efficiency. The formulation of the optimized formula was verified by Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), and X-ray Powder Diffraction (XRPD)...
February 9, 2024: Drug Development and Industrial Pharmacy
https://read.qxmd.com/read/38323684/mirtazapine-versus-megestrol-acetate-in-treatment-of-anorexia-cachexia-in-advanced-cancer-patients-a-randomized-double-blind-trial
#39
JOURNAL ARTICLE
Iftekhar Hossain Chowdhury, Md Sayedur Rahman, Md Najmul Kabir Chowdhury, Yeasmin Jahan Afroze, Masuma Tabassum, Muhammad Marnush, Nusrat Zerin
OBJECTIVE: Cancer-related anorexia-cachexia comprises one of the most common syndromes of advanced cancer patients. The management of cancer-related anorexia-cachexia is a great challenge in clinical practice. There are no definite practice guidelines yet for the prevention and treatment of cancer-related anorexia-cachexia. This study is considered to find out whether there is any role of mirtazapine in the improvement of anorexia in cancer patients. METHODS: A total of 80 cancer-anorexia patients were enrolled...
February 6, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38321853/progressive-multifocal-leukoencephalopathy-with-a-benign-prognosis-in-an-immunocompetent-patient-a-case-report
#40
Özdemir Zeynep, Teker Ruken Serap, Yüksel Burcu, Soysa Aysun
<p>John Cunningham virus (JCV) is most commonly acquired in childhood and is often asymptomatic throughout life. However, in the case of primary or secondary immunosuppression, it is known to cause progressive multifocal leukoencephalopathy (PML) in the central nervous system. Hereby, we describe a rare case of PML in a patient without known factors of immunosuppression or use of immunomodulation. A 53-year-old female patient was presented with progressive left-side weakness and tremors in the left hand over a period of two months...
January 30, 2024: Ideggyógyászati Szemle
keyword
keyword
67229
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.